Ryvu Therapeutics S.A. (WSE:RVU)

Ryvu Therapeutics Revenue

Ryvu Therapeutics had revenue of 21.71M PLN in the quarter ending March 31, 2026, with 3.20% growth. This brings the company's revenue in the last twelve months to 88.41M, down -9.40% year-over-year. In the year 2025, Ryvu Therapeutics had annual revenue of 87.73M, down -14.03%.

• Revenue (ttm): 88.41M
• Revenue Growth: -9.40%
• P/S Ratio: 3.92
• Revenue / Employee: 387.63K
• Employees: 228
• Market Cap: 346.80M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	87.73M	-14.31M	-14.03%
Dec 31, 2024	102.05M	34.05M	50.08%
Dec 31, 2023	67.99M	-2.50M	-3.54%
Dec 31, 2022	70.49M	34.36M	95.08%
Dec 31, 2021	36.13M	-1.19M	-3.20%
Dec 31, 2020	37.33M	3.19M	9.34%
Dec 31, 2019	34.14M	-71.73M	-67.75%
Dec 31, 2017	105.87M	39.15M	58.68%
Dec 31, 2016	66.72M	10.64M	18.98%
Dec 31, 2015	56.08M	14.52M	34.94%
Dec 31, 2014	41.56M	19.64M	89.63%
Dec 31, 2013	21.91M	-	-

Data Source: Fiscal.ai Last updated: May 20, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 22, 2026

Data Sources Report a data error